文献速递消化道肿瘤与早癌

系统生物学分析显示食管癌中转化生长因子-β和JNK信号通路过度激活

Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.
PubMed 文献 · Gastroenterology · 2019-02-12

研究对397例Barrett食管(BE)及食管腺癌(EAC)活检组织进行RNA测序和系统生物学分析,发现超过80%的EAC样本中转化生长因子-β(TGFB)和/或Jun N末端激酶(JNK)信号通路过度激活;药物抑制或敲低这些通路可显著减少EAC细胞增殖、迁移及裸鼠移植瘤生长,作者认为阻断这些通路可能用于EAC治疗。

要点

  • 超过80%的EAC样本中TGFB和/或JNK信号通路过度激活。
  • 药物抑制或敲低TGFB或JNK通路成分可显著减少EAC细胞增殖、迁移和移植瘤生长。
  • 抑制TGFB通路可减少发育不良BE细胞增殖,但不减少非发育不良BE细胞增殖。

核心结论

  • 在EAC和非发育不良BE组织的转录组分析中,发现TGFB和JNK信号通路在EAC中过度激活,且这些通路调控的基因在EAC和发育不良BE中过表达。
  • 抑制这些通路可减少EAC细胞增殖、迁移和移植瘤形成,作者认为阻断TGFB和JNK信号通路的策略可能被开发用于EAC治疗。

研究设计与样本

  • 收集397例EAC和非恶性Barrett食管(BE)伴或不伴发育不良的活检标本,进行RNA测序和系统生物学分析。
  • 用免疫组化和定量实时聚合酶链反应分析患者组织样本中信号成分以确认通路活性。
  • 用人EAC细胞(FLO-1和EsoAd1)、发育不良BE细胞(CP-B、CP-C、CP-D)和非发育不良BE细胞(CP-A)与药物抑制剂孵育或转染小干扰RNA,测量对增殖、集落形成、迁移和/或裸鼠移植瘤生长的影响。

主要发现

  • EAC与非发育不良BE组织比较显示,超过80%的EAC样本中TGFB和/或JNK信号通路过度激活。
  • 免疫组化分析显示,与正常组织相比,EAC肿瘤组织中磷酸化JUN和SMAD蛋白的核定位增加。
  • TGFB和JNK通路调控的基因在EAC和发育不良BE中特异性过表达。
  • 在EAC细胞(FLO-1或EsoAd1)中药理抑制或敲低TGFB或JNK信号成分,以不依赖SMAD4的方式显著减少细胞增殖、集落形成、细胞迁移和/或小鼠移植瘤生长。
  • 在BE细胞系中抑制TGFB通路可减少发育不良细胞增殖,但不减少非发育不良细胞增殖。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Esophageal adenocarcinoma (EAC) is resistant to standard chemoradiation treatments, and few targeted therapies are available. We used large-scale tissue profiling and pharmacogenetic analyses to identify deregulated signaling pathways in EAC tissues that might be targeted to slow tumor growth or progression. METHODS: We collected 397 biopsy specimens from patients with EAC and nonmalignant Barrett's esophagus (BE), with or without dysplasia. We performed RNA-sequencing analyses and used systems biology approaches to identify pathways that are differentially activated in EAC vs nonmalignant dysplastic tissues; pathway activities were confirmed with immunohistochemistry and quantitative real-time polymerase chain reaction analyses of signaling components in patient tissue samples. Human EAC (FLO-1 and EsoAd1), dysplastic BE (CP-B, CP-C, CP-D), and nondysplastic BE (CP-A) cells were incubated with pharmacologic inhibitors or transfected with small interfering RNAs. We measured effects on proliferation, colony formation, migration, and/or growth of xenograft tumors in nude mice. RESULTS: Comparisons of EAC vs nondysplastic BE tissues showed hyperactivation of transforming growth factor-β (TGFB) and/or Jun N-terminal kinase (JNK) signaling pathways in more than 80% of EAC samples. Immunohistochemical analyses showed increased nuclear localization of phosphorylated JUN and SMAD proteins in EAC tumor tissues compared with nonmalignant tissues. Genes regulated by the TGFB and JNK pathway were overexpressed specifically in EAC and dysplastic BE. Pharmacologic inhibition or knockdown of TGFB or JNK signaling components in EAC cells (FLO-1 or EsoAd1) significantly reduced cell proliferation, colony formation, cell migration, and/or growth of xenograft tumors in mice in a SMAD4-independent manner. Inhibition of the TGFB pathway in BE cell lines reduced the proliferation of dysplastic, but not nondysplastic, cells. CONCLUSIONS: In a transcriptome analysis of EAC and nondysplastic BE tissues, we found the TGFB and JNK signaling pathways to be hyperactivated in EACs and the genes regulated by these pathways to be overexpressed in EAC and dysplastic BE. Inhibiting these pathways in EAC cells reduces their proliferation, migration, and formation of xenograft tumors. Strategies to block the TGFB and JNK signaling pathways might be developed for treatment of EAC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Blum AE, Venkitachalam S, Ravillah D, et al. Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer. Gastroenterology. 2019. PMID: 30768984. doi:10.1053/j.gastro.2019.01.263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。